We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Andrew Partheniou

Andrew Partheniou

Vice President, Research

Healthcare, Cannabis & Psychedelics


[email protected] | (514) 288-2256 | v-Card | View Coverage
Andrew Partheniou is a Research Analyst at Stifel GMP covering the Healthcare sector. He joined the predecessor firm, GMP Securities L.P. (“GMP”), in 2017. Andrew provided support to Martin Landry who has been ranked as a TopGun Analyst in the Small Cap/Special Situations and Healthcare sectors in the Brendan Wood International Worldwide Equity Capital Markets Performance - Canadian Equities Report. Andrew has a technical background stemming from his years at a global engineering conglomerate and holds both a B. Eng. from McGill University, and an MBA from the John Molson School of Business.